ScoreWhy is Tianjin Lisheng Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 1.82%
- The company has been able to generate a Return on Capital Employed (avg) of 1.82% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 3.49% and Operating profit at 56.75% over the last 5 years
3
Flat results in Mar 26
- INTEREST(9M) At CNY 1.43 MM has Grown at 7.67%
- PRE-TAX PROFIT(Q) At CNY 60.96 MM has Fallen at -46.24%
- NET PROFIT(Q) At CNY 50.73 MM has Fallen at -51.03%
4
With ROE of 9.05%, it has a very attractive valuation with a 0.92 Price to Book Value
- Over the past year, while the stock has generated a return of -7.27%, its profits have risen by 127.8% ; the PEG ratio of the company is 0.1
- At the current price, the company has a high dividend yield of 4.6
5
Below par performance in long term as well as near term
- Along with generating -7.27% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Tianjin Lisheng Pharmaceutical Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Tianjin Lisheng Pharmaceutical Co., Ltd.
-100.0%
-0.22
41.63%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.49%
EBIT Growth (5y)
56.75%
EBIT to Interest (avg)
45.74
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
0.26
Tax Ratio
6.95%
Dividend Payout Ratio
54.50%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.75%
ROE (avg)
3.32%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.93
EV to EBIT
18.45
EV to EBITDA
11.65
EV to Capital Employed
0.85
EV to Sales
1.40
PEG Ratio
0.08
Dividend Yield
4.49%
ROCE (Latest)
4.62%
ROE (Latest)
9.05%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 371.51 MM
CASH AND EQV(HY)
Highest at CNY 4,831.86 MM
-22What is not working for the Company
PRE-TAX PROFIT(Q)
At CNY 33.02 MM has Fallen at -70.52%
NET PROFIT(Q)
At CNY 26.71 MM has Fallen at -73.99%
ROCE(HY)
Lowest at 3.2%
RAW MATERIAL COST(Y)
Grown by 6.48% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.95 times
NET SALES(Q)
At CNY 309.35 MM has Fallen at -8.24%
EPS(Q)
Lowest at CNY 0.09
Here's what is working for Tianjin Lisheng Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 371.51 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Cash and Eqv
Highest at CNY 4,831.86 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Tianjin Lisheng Pharmaceutical Co., Ltd.
Pre-Tax Profit
At CNY 33.02 MM has Fallen at -70.52%
over average net sales of the previous four periods of CNY 112.03 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 26.71 MM has Fallen at -73.99%
over average net sales of the previous four periods of CNY 102.67 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Net Sales
At CNY 309.35 MM has Fallen at -8.24%
over average net sales of the previous four periods of CNY 337.11 MMMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
EPS
Lowest at CNY 0.09
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Debtors Turnover Ratio
Lowest at 1.95 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 6.48% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
